Enrichment, Training, and Outreach in the Stanford DRC Stanford University and School of Medicine are renowned leaders in education, scientific innovation, patient care and entrepreneurship. A central aspect of the Stanford Diabetes Research Center (SDRC) Enrichment, Training, and Outreach Program is to leverage these strengths to enhance diabetes research and training. The goals of the SDRC Enrichment, Training and Outreach Program (ETOP) are: 1) To advance diabetes research by serving as the organizing nexus of enrichment activities to foster interdisciplinary education, idea sharing and collaboration; 2) To attract, support and train future diabetes research leaders who will advance diabetes-related knowledge and improve patient care; 3) To facilitate and support the numerous local and national community outreach programs that Stanford has established to improve patient awareness, empowerment and advocacy. The SDRC enhances the environment for diabetes research and training at Stanford through multiple efforts including the establishment of diabetes-research affinity groups to facilitate knowledge-sharing and collaboration, a monthly diabetes research-in-progress seminar series, multiple lecture series for invited speakers, an annual Diabetes Research Day Symposium that showcases new and evolving ideas in the field, a spectrum of training grant opportunities including NIH T32 training programs and numerous patient-oriented events that occur on campus as well as within the community.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
1P30DK116074-01
Application #
9442595
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
1
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Kovary, Kyle M; Taylor, Brooks; Zhao, Michael L et al. (2018) Expression variation and covariation impair analog and enable binary signaling control. Mol Syst Biol 14:e7997
Mahajan, Anubha (see original citation for additional authors) (2018) Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes. Nat Genet 50:559-571
Abdolazimi, Yassan; Zhao, Zhengshan; Lee, Sooyeon et al. (2018) CC-401 Promotes ?-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition. Endocrinology 159:3143-3157
Mahajan, Anubha; Taliun, Daniel; Thurner, Matthias et al. (2018) Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet 50:1505-1513
Fall, Tove; Gustafsson, Stefan; Orho-Melander, Marju et al. (2018) Genome-wide association study of coronary artery disease among individuals with diabetes: the UK Biobank. Diabetologia :
Nagy, Nadine; de la Zerda, Adi; Kaber, Gernot et al. (2018) Hyaluronan content governs tissue stiffness in pancreatic islet inflammation. J Biol Chem 293:567-578
Rao, Abhiram S; Lindholm, Daniel; Rivas, Manuel A et al. (2018) Large-Scale Phenome-Wide Association Study of PCSK9 Variants Demonstrates Protection Against Ischemic Stroke. Circ Genom Precis Med 11:e002162
Shen, Wen-Jun; Asthana, Shailendra; Kraemer, Fredric B et al. (2018) Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function. J Lipid Res 59:1114-1131
Nowak, Christoph; Hetty, Susanne; Salihovic, Samira et al. (2018) Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance. Sci Rep 8:8691
Bahrami-Nejad, Zahra; Zhao, Michael L; Tholen, Stefan et al. (2018) A Transcriptional Circuit Filters Oscillating Circadian Hormonal Inputs to Regulate Fat Cell Differentiation. Cell Metab 27:854-868.e8

Showing the most recent 10 out of 46 publications